Press release
Creative Diagnostics Announces the Availability of Novel Cyclopiazonic Acid Test Reagents
Creative Diagnostics announces the release of its Cyclopiazonic Acid Test Reagents.Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for the analysis of food, feed, environmental and toxicological samples, is excited to announce the release of its Cyclopiazonic Acid Test Reagents [https://www.creative-diagnostics.com/food-analysis/cyclopiazonic-acid.html] to help ensure food safety. These reagents are designed to support the development of sensitive and specific immunoassays for the detection of this mycotoxin in food and other matrices.
Cyclopiazonic acid (CPA) is an indole trichothecene toxin produced by several species of Penicillium, mainly Penicillium camemberti, Penicillium chrysogenum, Penicillium commune, Penicillium viridicatum and Penicillium griseofulvum. Some Aspergillus species, such as Aspergillus flavus and Aspergillus oryzae, can also produce CPA. Several authors have identified peanuts as the main source of this toxin, but studies have also shown that the toxin is present in products such as cereals, prosciutto, cheese, fruit and other nuts.
CPA is not acutely toxic, with an oral LD50 of 30-70 mg/kg in rodents. The main target of this toxin is the nervous system and it is therefore considered a neurotoxin. Ingestion of CPA results in signs of ataxia and, in extreme cases, death due to spastic paralysis. It can also cause gastrointestinal lesions. The effect of CPA exposure on cells is due to the inhibition of calcium channels in cells. The toxin is a potent and selective inhibitor of calcium ATPase activity.
Cyclopiazonic acid appears to be toxic only at high concentrations. The symptoms associated to CPA consumption also include anorexia, dehydration, weight loss, immobility and, in the case of near death, convulsions. Few cases of mycotoxicosis with cyclopiazonic acid have been reported because the poisoning is benign, the amount of toxicity is small, and the effects may be masked by concurrent aflatoxin poisoning (some toxicity data may have been derived from the use of aflatoxin-contaminated CPA). To date, there are no national regulations on CPA levels in food products.
Consumption of CPA-contaminated foods can pose health risks and it is therefore essential to monitor food products for the presence of this mycotoxin. Creative Diagnostics' new Cyclopiazonic Acid test reagents are highly sensitive and specific and can be used with a variety of analytical methods including ELISA and LFIA. These reagents, such as Cyclopiazonic Acid Antibodies & Antigens, Cyclopiazonic Acid ELISA Kits, and Cyclopiazonic Acid Screen Tests, are also easy to use and require minimal sample preparation.
Creative Diagnostics is committed to providing high-quality research reagents and diagnostic solutions to support the development of new and innovative mycotoxin detection technologies. To know more about the new Cyclopiazonic Acid Test Reagents and other food safety solutions, please visit https://www.creative-diagnostics.com/food-analysis/cyclopiazonic-acid.html.
About Creative Diagnostics
Creative Diagnostics is a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for the analysis of food, feed, environmental and toxicological samples. Its product portfolio covers a wide range of analytes including mycotoxins, drug residues, pesticides, contaminants, food allergens, food pathogens and vitamins. The company also assists customers in the rapid development, manufacture and commercialization of small molecule antigens, antibodies and food safety lateral flow strips for any market segment.
Media Contact
Company Name: Creative Diagnostics
Contact Person: Thomas Schmitt
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=creative-diagnostics-announces-the-availability-of-novel-cyclopiazonic-acid-test-reagents]
State: New York
Country: United States
Website: https://www.creative-diagnostics.com/food-analysis/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Creative Diagnostics Announces the Availability of Novel Cyclopiazonic Acid Test Reagents here
News-ID: 3755088 • Views: …
More Releases from ABNewswire
Active Implantable Medical Devices Market Is Expected to Reach USD 44,906.36 mil …
The leading companies operating in the active implantable medical devices market include Medtronic, Johnson and Johnson Services, Inc., Abbott, Boston Scientific Corporation, LivaNova PLC., Axonics, Inc., Aleva Neurotherapeutics, Sonova Holding AG, Bioventus Inc., CARMAT, Jarvik Heart Inc., BIOTRONIK SE & Co. KG, MicroTransponder Inc., MED-EL Medical Electronics, NeuroPace, Inc., NEVRO CORP., Shree Pacetronix, Cochlear Ltd., Berlin Heart, Blackrock Neurotech, and others.
DelveInsight's "Active Implantable Medical Devices Market Insights, Competitive Landscape, and…
Global Heparin Market Poised to Reach USD 18.19 Billion by 2032, Driven by Risin …
Major players shaping the global heparin market include Pfizer Inc., Dr. Reddy's Laboratories Ltd., Gland Pharma Limited, Sanofi, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Novartis AG, Baxter, Leo Pharma A/S, and Cardinal Health. Continuous investments in R&D, formulation improvements, mergers, and global distribution partnerships remain vital elements of their growth strategy.
DelveInsight's "Heparin Market Insights, Competitive Landscape, and Market Forecast - 2032" report delivers a comprehensive analysis of…
Global Phage Therapy Pipeline Accelerates as 20+ Biotech Companies Advance Next- …
Key phage therapy companies such as Locus Biosciences, Armata Pharmaceuticals, BiomX, SNIPR Biome, Phagelux, PHAXIAM Therapeutics, Phico Therapeutics, Technophage, and others.
DelveInsight's 'Phage Therapies Competitive Landscape 2025' report provides comprehensive global coverage of pipeline phage therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the phage therapies pipeline domain.
The phage therapy market is witnessing robust growth driven by…
Systemic Juvenile Idiopathic Arthritis Market Analysis 2034 - Competitive Landsc …
Systemic Juvenile Idiopathic Arthritis Companies are Chugai Pharmaceutical, AstraZeneca, Pfizer, Incyte Corporation Novartis, Roche, Genentech, AbbVie, Pfizer, Eli Lilly and Company, Bristol Myers Squibb, Johnson & Johnson, Merck & Co., UCB, Sanofi, and others.
DelveInsight's "Systemic Juvenile Idiopathic Arthritis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Systemic Juvenile Idiopathic Arthritis, historical and forecasted epidemiology as well as the Systemic Juvenile Idiopathic Arthritis market trends in the…
More Releases for Creative
GPCR Screening Service Market Industry Dynamics and Contributions by Profacgen, …
The GPCR (G-Protein Coupled Receptor) Screening Service Market is at the forefront of biopharmaceutical research and drug discovery. GPCRs are pivotal in numerous physiological processes, making them prime targets for therapeutic intervention. As the scientific community continues to unravel the complexities of GPCRs, the demand for specialized screening services is surging. The market encompasses a wide range of applications, including drug development, diagnostics, and therapeutic interventions, thereby broadening its relevance.
Recent…
Creative Biolabs: Creative Thoughts to Shake Up the mRNA R&D
Creative Biolabs offers top-notch mRNA technology support to fuel emerging therapeutic discoveries.
New York, USA - July 16, 2024 - Recent headlines have been dominated by the transformative potential of mRNA-based therapies, extending beyond infectious diseases to encompass cancer, genetic disorders, and autoimmune conditions. This surge in interest underscores the importance of reliable and innovative partners in mRNA research and development. Creative Biolabs stands out as a pivotal player, providing comprehensive…
Creative Biolabs: Creative Thoughts to Shake Up mRNA R&D
Creative Biolabs offers top-notch mRNA technology support to fuel emerging therapeutic discoveries.
New York, USA - July 2, 2024 - Recent headlines have been dominated by the transformative potential of mRNA-based therapies, extending beyond infectious diseases to encompass cancer, genetic disorders, and autoimmune conditions. This surge in interest underscores the importance of reliable and innovative partners in mRNA research and development. Creative Biolabs stands out as a pivotal player, providing comprehensive…
Art Eeets Business: Creative Workspaces, Creative Working With AltF Coworking Ok …
AltF Coworking in Okhla redefines the work life for working professionals by creating a supreme work experience where elevating, luxurious, and professional workspaces attract the attention of employees and owners who wish for a change in their work lives. With the launch of the latest property of AltF Coworking in Okhla, the work life of corporate professionals has been transformed to a large extent.
[NEW DELHI, 21st December 2023] -…
creative@allstatescorp.com
To safeguard, enhance, and advance men's prostate health, prostadine was created. This natural treatment is superior to many other prostate supplements since it deals with the root causes of the condition.
Prostadine Reviews from Actual Users
Anxiety levels are rising as a result of our modern culture's increased reliance on technology and media. We are unable to give our health the care it deserves due to the pressures of modern living. Therefore,…
Membrane Protein Characterization Service Market 2018-2028 by Key Prominent Play …
Membrane Protein Characterization Service Market Insights
Membrane protein characterization at atomic resolution is always a big challenge in development of membrane protein-based antibody as well as small molecule drugs. The development of these membrane protein related antibodies and vaccines require high resolution structural information of target protein. Thus membrane protein characterization plays a vital role in drug discovery, propelling the demand for membrane protein characterization Service across the world. In order…
